多巴胺 (药物)

维基百科,自由的百科全书
Dopamine
临床资料
商品名英语Drug nomenclatureIntropin、Dopastat、Revimine等
其他名称2-(3,4-Dihydroxyphenyl)ethylamine; 3,4-Dihydroxyphenethylamine; 3-hydroxytyramine; DA; Intropin; Revivan; Oxytyramine; Prolactin inhibiting factor; Prolactin inhibiting hormone
AHFS/Drugs.comMonograph
核准状况
给药途径静脉注射
ATC码
生理学数据
来源组织黑质腹侧被盖区等区域
目标组织System-wide
受体D1英语Dopamine receptor D1D2D3英语Dopamine receptor D3, D4D5英语Dopamine receptor D5TAAR1英语TAAR1[1]
激动剂直接受体激动剂:阿朴吗啡英语apomorphine溴隐亭
激动剂英语Indirect agonist可卡因苯丙胺
拮抗剂抗精神病药metoclopramide多潘立酮
药物代谢MAOCOMT[1]ALDH英语aldehyde dehydrogenaseDBHMAO-A英语Monoamine oxidase AMAO-B英语Monoamine oxidase BCOMT
法律规范状态
法律规范
  • 处方药(-only)
药物动力学数据
药物代谢MAOCOMT[1]ALDH英语aldehyde dehydrogenaseDBHMAO-A英语Monoamine oxidase AMAO-B英语Monoamine oxidase BCOMT
排泄途径肾脏
识别信息
  • 4-(2-Aminoethyl)benzene-1,2-diol
CAS号51-61-6  checkY
62-31-7(hydrochloride)
PubChem CID
IUPHAR/BPS
DrugBank
ChemSpider
UNII
KEGG
ChEBI
ChEMBL
化学信息
化学式C8H11NO2
摩尔质量153.18 g/mol
3D模型(JSmol英语JSmol
密度1.26 g/cm3
熔点128 °C(262 °F)
沸点降解
  • c1cc(c(cc1CCN)O)O
  • InChI=1S/C8H11NO2/c9-4-3-6-1-2-7(10)8(11)5-6/h1-2,5,10-11H,3-4,9H2 checkY
  • Key:VYFYYTLLBUKUHU-UHFFFAOYSA-N checkY

多巴胺(Dopamine)药品名称有恩得品(Intropin)等,是常用来治疗休克、有导致其他症状的心跳过缓的药物[2],若心搏停止,又没有肾上腺素的情形下,也可用多巴胺治疗[2]

多巴胺也是治疗婴儿严重低血压的首选药物[3]。若是儿童低血压,一般会用肾上腺素正肾上腺素英语Norepinephrine (medication)治疗,成人则会用正肾上腺素治疗[4][5]。多巴胺可用静脉注射骨内注射英语Intraosseous infusion的方式持续给药[2],药效一般会在五分钟后开始[2],之后可以适度增加剂量以达到最佳药效[2]

常见的副作用包括肾功能恶化、心律不整心绞痛呕吐头痛、焦虑[2],若外渗英语Extravasation (intravenous)到血管附近的软组织,可能会有局部的组织坏死英语tissue necrosis[2],此时可以试着用酚妥拉明英语phentolamine来降低风险[2]。还不确定在妊娠母乳哺育中使用多巴胺的安全性[2]。低剂量的多巴胺会触发多巴胺受体β1-肾上腺素能受体英语β1-adrenergic receptor,高剂量的多巴胺则会透过α-肾上腺素能受体英语α-adrenergic receptor作用[2]

多巴胺最早是在1910年由George Barger及James Ewens在英国实验室所制备[6],是世界卫生组织基本药物标准清单中的药物,于医疗系统所需最有效及安全的药物之一[7]。 2014年在发展中国家中,400mg的多巴胺药价在美金0.28元至0.60元之间[8]。人体内也有自然产生的多巴胺,类似激素一样是神经递质[9]

参考资料[编辑]

  1. ^ 1.0 1.1 Dopamine: Biological activity. IUPHAR/BPS guide to pharmacology. International Union of Basic and Clinical Pharmacology. [2016-01-29]. (原始内容存档于2016-02-05). 
  2. ^ 2.00 2.01 2.02 2.03 2.04 2.05 2.06 2.07 2.08 2.09 Dopamine Hydrochloride. drugs.com. American Society of Health-System Pharmacists. 2016-06-29 [2016-07-15]. (原始内容存档于2016-09-14). 
  3. ^ Bhayat, SI; Gowda, HM; Eisenhut, M. Should dopamine be the first line inotrope in the treatment of neonatal hypotension? Review of the evidence.. World journal of clinical pediatrics. 2016-05-08, 5 (2): 212–22. PMC 4857235可免费查阅. PMID 27170932. doi:10.5409/wjcp.v5.i2.212. 
  4. ^ De Backer, D; Aldecoa, C; Njimi, H; Vincent, JL. Dopamine versus norepinephrine in the treatment of septic shock: a meta-analysis*.. Critical Care Medicine. March 2012, 40 (3): 725–30. PMID 22036860. doi:10.1097/ccm.0b013e31823778ee. 
  5. ^ Dellinger, RP; Levy, MM; Rhodes, A; Annane, D; Gerlach, H; Opal, SM; Sevransky, JE; Sprung, CL; Douglas, IS; Jaeschke, R; Osborn, TM; Nunnally, ME; Townsend, SR; Reinhart, K; Kleinpell, RM; Angus, DC; Deutschman, CS; Machado, FR; Rubenfeld, GD; Webb, SA; Beale, RJ; Vincent, JL; Moreno, R; Surviving Sepsis Campaign Guidelines Committee including the Pediatric, Subgroup. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012.. Critical Care Medicine. February 2013, 41 (2): 580–637. PMID 23353941. doi:10.1097/CCM.0b013e31827e83af. 
  6. ^ Fahn S. The history of dopamine and levodopa in the treatment of Parkinson's disease. Movement Disorders. 2008,. 23 Suppl 3: S497–508. PMID 18781671. doi:10.1002/mds.22028. According to Hornykiewicz,6 dopamine was first synthesized by George Barger and James Ewens in 1910 at the Wellcome labs in London, England. 
  7. ^ WHO Model List of Essential Medicines (19th List) (PDF). World Health Organization. April 2015 [2016-12-08]. (原始内容存档 (PDF)于2016-12-13). 
  8. ^ Dopamine. International Drug Price Indicator Guide. [2015-12-05]. (原始内容存档于2020-04-14). 
  9. ^ Millar, Thomas. Biochemistry explained : a practical guide to learning biochemistry. London: Routledge. 2002: 40 [2017-12-08]. ISBN 9780415299411. (原始内容存档于2016-08-15).